Kara, M. et al. 2025. Real-World Outcomes of Baricitinib Monotherapy Versus csDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy, Safety, and Drug Retention. Archives of Rheumatology. 40, 3 (Sep. 2025), 279–287. DOI:https://doi.org/10.5152/ArchRheumatol.2025.11131.